KNSA CIK: 1730430

Kiniksa Pharmaceuticals International, plc

  • United Kingdom
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
196
FY22:
243
FY23:
276
FY24:
332
FY25:
527
(positive)
Change from FY21 to FY25
millions USD
FY21:
36.4
FY22:
217
FY23:
250
FY24:
249
FY25:
236
Total assets
Change from FY21 to FY25
millions USD
FY21:
233
FY22:
460
FY23:
526
FY24:
581
FY25:
764

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
44.8
FY22:
47.1
FY23:
63.7
FY24:
101
FY25:
139
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.94
FY22:
16.5
FY23:
23.8
FY24:
41.5
FY25:
56.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
185
FY22:
396
FY23:
439
FY24:
438
FY25:
568
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
233
FY22:
460
FY23:
526
FY24:
581
FY25:
764

All amounts in millions USD Data source:SEC EDGAR